further pharmacologic characterization with the 5-ht1a ligands 8-hydroxy-2- ( di-n-propylamino ) tetralin , ipsapirone , and wb4101 and the butyrophenone compounds spiperone and haloperidol gave results that were consistent with [ 3h ] spiroxatrine labeling 5-ht1a sites .
C0006525
butyrophenone
C0037956
spiperone